KRISMEIKESARI KRISMEIKESARI. Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis. Open Access Indonesian Journal of Medical Reviews, v. 5, n. 6, p. 1772-1789, 12 Nov. 2025.